Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy

Journal of the Neurological Sciences

Volumn 165, Issue 1, 1999, Pages 10-17

  Cock, H R ^a   Cooper, J M ^a   Schapira, A H V ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ATP; Complex I; Leber's hereditary optic neuropathy; Mitochondria; Mitochondrial DNA

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ARTICLE; BASE MISPAIRING; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE MUTATION; HEREDITARY OPTIC ATROPHY; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL;

EID: 0033137096     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00088-X     Document Type: Article

References (35)

1. Wallace D.C. Mitochondrial genetics: a paradigm for ageing and degenerative diseases? Science. 256:1992;628-632.
2. Darley-Usmar V.M., Ragan C.I., Smith P.R., Wilson M.T. The proteins of the mitochondrial inner membrane and their role in oxidative phosphorylation. Darley-Usmar V.M., Schapira A.H.V. Mitochondria: DNA, proteins and disease. 1994;1-27 Portland Press, London.
3. Walker J.E. The NADH-ubiquinone oxidoreductase (complex I) of respiratory chains. Q Rev Biophys. 25:1992;253-324.
4. Suzuki K., Mizuno Y., Yoshida M. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline. Neurosci Lett. 86:1988;105-108.
5. Vazquez-Memije M.E., Shankse S., Santorelli F.M., Kranz-Eble P., Davidson E., DiVivo D.C., DiMauro S. Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherit Metab Dis. 19:1996;43-50.
6. Wanders R.J.A., Ruiter J.P.N., Wijberg F.A. Studies on mitochondrial oxidative phosphorylation in permeabilised human skin fibroblasts: application to mitochondrial encephalomyopathies. Biochim Biophys Acta. 1181:1993;219-222.
7. Davey G.P., Clark J.B. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J Neurochem. 66:1996;1617-1624.
8. Letellier T., Malgat M., Mazat J. Control of oxidative phosphorylation in rat muscle mitochondria: implications for mitochondrial myopathies. Biochim Biophys Acta. 1141:1993;58-64.
9. Letellier T., Heinrich R., Malgat M., Mazat J. The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem J. 302:1994;171-174.
10. Taylor R.W., Birch-Machin B.A., Bartlett K., Lowerson S.A., Turnbull D.M. The control of mitochondrial oxidation by complex III in rat muscle and liver mitochondria. J Biol Chem. 269:1994;3523-3528.
11. Majander A., Huoponen K., Savontaus M., Nikoskelainen E.K., Wikström M. Electron transfer properties of NADH-ubiquinone reductase in the NA1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett. 292:1991;289-292.
12. Howell N., Bindoff L.A., McCullough D.A., Kubacka I., Mackey D., Taylor L., Turnbull D.M., Poulton J. Leber's hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet. 49:1991;939-950.
13. Smith P.R., Cooper J.M., Govan G.G., Harding A.E., Schapira A.H.V. Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci. 122:1994;80-83.
14. Singer T.P., Ramsay R.R. The reaction sites of rotenone and ubiquinone with mitochondrial NADH dehydrogenase. Biochim Biophys Acta. 1187:1994;198-202.
15. Parker W.D., Oley C.A., Parks J.K. Differences between the means of two small samples - population variances not assumed to be equal. In: Introductory statistics for biology. N Engl J Med. 320:1989;1331-1333.
16. Cock H.R., Cooper J.M., Schapira A.H.V. The 14484 ND6 mtDNA mutation in Leber hereditary optic neuropathy does not affect fibroblast complex I activity. Am J Hum Genet. 57:1995;1501-1502.
17. Howell N., Kubacka I., Xu M., McCullough D.A. Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet. 48:1991;935-942.
18. Larsson N., Andersen A., Holme E., Oldfors A., Wahlström M.D. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol. 30:1991;704-708.
19. Majander A., Finel M., Savontaus M.L., Nikoskelainen E., Wikstrom M. Catalytic activity of complex I in cell lines that possess replacement mutations in the ND genes in Leber's hereditary optic neuropathy. Eur J Biochem. 239:1996;201-207.
20. Degli Esposti M.D., Carelli V., Ghelli A., Ratta M., Crimi M., Sangiorgi S., Montagna P., Lenaz G., Lugaresi E., Cortelli P. Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber's hereditary optic neuropathy. FEBS Lett. 352:1994;375-379.
21. Cortelli P., Montagna P., Avoni P., Sangiorgi S., Bresolin N., Moggio M., Zaniol P., Mantovani V., Barboni P., Barbiroli B., Lugaresi E. Leber's hereditary optic neuropathy: genetic, biochemical, and phosphorus magnetic resonance spectroscopy study in an Italian family. Neurology. 41:1991;1211-1215.
22. 31P magnetic resonance spectroscopy. Ann Neurol. 42:1997;573-579.
23. Martin G.M. Human skin fibroblasts. Kruse P.F.J., Patterson M.K.J. Tissue culture methods and applications. 1973;39-43 Academic Press, New York.
24. Cock H.C., Tabrizi S.J., Cooper J.M., Schapira A.H.V. The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy. Ann Neurol. 44:1998;187-193.
25. Rickwood D., Wilson M.T., Darley-Usmar V.M. Isolation and characteristics of intact mitochondria. Darley-Usmar V.M., Rickwood D., Wilson M.T. Mitochondria: a practical approach. 1987;1-16 IRL Press, Oxford.
26. Coore H.G., Denton R.M., Martin B.R., Randle P.J. Regulation of adipose tissue pyruvate dehydrogenase by insulin and other hormones. Biochem J. 125:1971;115-127.
27. Hatefi Y., Rieske J.S. Preparation and properties of DPNH coenzyme q reductase (complex I of the respiratory chain). Methods Enzymol. 1967;225-231.
28. Wharton D.C., Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 10:1967;245-257.
29. Krige D., Carroll M.T., Cooper J.M., Marsden C.D., Schapira A.H.V. Platelet mitochondrial function in Parkinson's disease. Ann Neurol. 32:1992;782-788.
30. Williamson J.R., Corkey B. Assays of intermediates of the citric acid cycle and related compounds by fluorimetric enzyme methods. Methods Enzymol. 13:1969;435-573.
31. 3H]dihydrorotenone. FEBS Lett. 219:1987;108-113.
32. Vinogradov A.D., Sled V.D., Burbaev D.S., Grivennikova V.G., Moroz I.A., Ohnishi T. Energy-dependent complex I-associated ubisemiquinones in submitochondrial particles. FEBS Lett. 370:1995;83-87.
33. Yagi T. Inhibition of NADH-ubiquinone reductase activity by N,N′ -dicyclohexylcarbodiimide and correlation of this inhibition with the occurrence of energy coupling site 1 in various organisms. Biochemistry. 26:1987;2822-2828.
34. VanBelzen R., Albracht S.P.J. The pathway of electron transfer in NADH:Q oxidoreductase. Biochim Biophys Acta. 974:1989;311-320.
35. Anderson W.M., Trgovcich-Zacok D. Evidence for three separate electron flow pathways through complex I: an inhibitor study. Biochim Biophys Acta. 1230:1995;186-193.